Literature DB >> 24154499

[Functional gastrointestinal diseases].

J Keller1, P Layer.   

Abstract

Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are the most important functional gastrointestinal diseases (FGID), and both affect about 5-15 % of the German population. The patients' symptoms are caused by disturbances of gastrointestinal (GI) motility, secretion and sensitivity. Central processing of visceral afferences is disturbed, and the course of the disease and individual symptom perception are influenced by psychosocial factors. Diagnosis of FD and IBS is based on a compatible symptom pattern, absence of alarm symptoms and exclusion of relevant differential diagnoses. The diagnosis of FD requires a normal upper GI endoscopy. Current German guidelines also demand a normal colonoscopy for diagnosis of IBS. Basic therapeutic measures include explanation of the nature of the disease and its harmlessness quo ad vitam . Individual trigger factors should be identified and eliminated if possible. Drug therapy of persisting complaints is guided by the dominant symptom.

Entities:  

Mesh:

Year:  2013        PMID: 24154499     DOI: 10.1007/s00108-013-3379-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  [Clinically relevant breath tests in gastroenterological diagnostics--recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases].

Authors:  J Keller; A Franke; M Storr; F Wiedbrauck; J Schirra
Journal:  Z Gastroenterol       Date:  2005-09       Impact factor: 2.000

2.  [Performance and interpretation of esophageal manometry: recommendations of the German Societies for Neurogastroenterology and Motility (DGNM), for Digestive and Metabolic Diseases (DGVS) and for General and Visceral Surgery (DGAV)].

Authors:  J Keller; I van der Voort; C Pehl; M Nicolaus; J Schirra; M Fox; K Fuchs; M Storr
Journal:  Z Gastroenterol       Date:  2009-09-11       Impact factor: 2.000

3.  [Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management].

Authors:  P Layer; V Andresen; C Pehl; H Allescher; S C Bischoff; M Classen; P Enck; T Frieling; S Haag; G Holtmann; M Karaus; S Kathemann; J Keller; R Kuhlbusch-Zicklam; W Kruis; J Langhorst; H Matthes; H Mönnikes; S Müller-Lissner; F Musial; B Otto; C Rosenberger; M Schemann; I van der Voort; K Dathe; J C Preiss
Journal:  Z Gastroenterol       Date:  2011-02-01       Impact factor: 2.000

4.  [S3 guideline of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) to the definition, pathophysiology, diagnosis and treatment of intestinal motility].

Authors:  J Keller; T Wedel; H Seidl; M E Kreis; V Andresen; J C Preiss; P Layer; I van der Voort
Journal:  Z Gastroenterol       Date:  2011-03-09       Impact factor: 2.000

5.  [Diagnosis of oesophageal reflux by PH, impedance, and bilirubin measurement: recommendations of the German Society of Neurogastroenterology and of the working group for neurogastroenterology of the German Society for Digestive and Metabolic Diseases].

Authors:  C Pehl; J Keller; H-D Allescher; H Feussner; T Frieling; M Goebel-Stengel; J Gschossmann; R Kuhlbusch-Zicklam; H Mönnikes; H N Nguyen; M Müller; J Schirra; M Storr; I van der Voort; B Yüce
Journal:  Z Gastroenterol       Date:  2012-12-07       Impact factor: 2.000

6.  Long-term improvement in functional dyspepsia using hypnotherapy.

Authors:  Emma Louise Calvert; Lesley Anne Houghton; Patricia Cooper; Julie Morris; Peter James Whorwell
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 7.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.

Authors:  Kok-Ann Gwee
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 9.  Postinfectious irritable bowel syndrome.

Authors:  Robin Spiller; Klara Garsed
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

10.  Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.

Authors:  E M M Quigley; J Tack; W D Chey; S S Rao; J Fortea; M Falques; C Diaz; S J Shiff; M G Currie; J M Johnston
Journal:  Aliment Pharmacol Ther       Date:  2012-11-01       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.